PURPOSE The integration of patient-reported outcomes (PROs) into electronic health
records (EHRs) has enabled systematic collection of symptom data to manage post …

Introduction Cancer cachexia is a clinical condition characterized by recognizable “sickness
behaviors” accompanied by loss of lean body tissue. The Global Leadership on Malnutrition …

The immune checkpoint inhibitor ipilimumab provides long term survival in some metastatic
melanoma patients, but the majority has no benefit, and may experience serious side effects …

Health related quality of life (HRQoL) is increasingly assessed in oncology research and
routine care, which has led to the inclusion of HRQoL in prediction models. This review aims …

Abstract Objective Patient-reported outcomes (PROs) that predict survival in cancer patients
have yet to be realized as practical tools for clinicians to make better treatment decisions. To …

Background: Immune checkpoint inhibitors (ICIs) offer a new treatment approach for cancer,
with an improvement in patient survival. However, it remains unclear whether their use …

Zusammenfassung Hintergrund und Ziel der Arbeit Die Therapie des malignen Melanoms
hat sich durch die Zulassung der zielgerichteten Therapie und Immuncheckpointinhibitoren …

Bakgrund: Malignt melanom är en cancer som finns i huden och är en sjukdom som kan ge
långvariga psykiska konsekvenser efter avslutad behandling. Detta är den allvarligaste …

Background The implementation of patient-reported outcome measures (PROMs) in the
clinical identification of immunotherapy toxicities is a complex intervention. There has been …

Background Australia has the highest incidence of melanoma in the world. Skin with many
melanocytic naevi (commonly known as moles), indicates a strong phenotypic risk for …